Similar articles

• The sound and the fury: an update on the role of high-dose chemotherapy and autologous stem cell salvage for both metastatic and high-risk breast cancer.

  Bar MH. Bar MH. Conn Med. 2000 Jan;64(1):3-6. Conn Med. 2000. PMID: 10697358 Review. No abstract available.
• Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.

  Hortobagyi GN, Buzdar AU, Theriault RL, Valero V, Frye D, Booser DJ, Holmes FA, Giralt S, Khouri I, Andersson B, Gajewski JL, Rondon G, Smith TL, Singletary SE, Ames FC, Sneige N, Strom EA, McNeese MD, Deisseroth AB, Champlin RE. Hortobagyi GN, et al. J Natl Cancer Inst. 2000 Feb 2;92(3):225-33. doi: 10.1093/jnci/92.3.225. J Natl Cancer Inst. 2000. PMID: 10655439 Clinical Trial.
• High-dose chemotherapy for breast cancer.

  Nieto Y, Shpall EJ. Nieto Y, et al. Cancer Treat Res. 2000;103:77-114. doi: 10.1007/978-1-4757-3147-7_5. Cancer Treat Res. 2000. PMID: 10948443 Review. No abstract available.
• High dose therapy with stem cell support for breast cancer: the jury is still out.

  Crump M, Pritchard K. Crump M, et al. Cancer Treat Res. 2000;103:115-36. doi: 10.1007/978-1-4757-3147-7_6. Cancer Treat Res. 2000. PMID: 10948444 Review. No abstract available.
• [High-dose chemotherapy for treatment of breast cancers].

  Tokuda Y. Tokuda Y. Nihon Rinsho. 2000 Apr;58 Suppl:292-7. Nihon Rinsho. 2000. PMID: 11026009 Review. Japanese. No abstract available.